Efficacy News and Research

RSS

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Sponge-like solar cells could form the basis for less-invasive pacemakers or similar medical devices

Holes help make sponges and English muffins useful (and, in the case of the latter, delicious). Without holes, they wouldn't be flexible enough to bend into small crevices, or to sop up the perfect amount of jam and butter.

7 Jun 2022

Novel approach to drug repurposing incorporates two-stage prediction and machine learning

A new study presents a novel approach to drug repurposing that incorporates two-stage prediction and machine learning.

7 Jun 2022

Study demonstrates how some fast-growing bacteria can evade antibiotic treatment

Scientists have demonstrated how some fast-growing bacteria can retreatment with antibiotics, according to a study published today in eLife.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

Study identifies some breast cancer patients who can avoid radiotherapy

Older women with early-stage breast cancer may not need radiotherapy after undergoing surgery, McMaster University researcher Timothy Whelan and his team has found.

7 Jun 2022

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Often undetected until it has progressed to an advanced stage, pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer.

6 Jun 2022

Color-changing mouse model aids in better visualization of internal physiology

Biomedical and genetic engineers at Duke University and the Albert Einstein College of Medicine have developed a process to change the color of a mouse's tissue in imaging to better visualize its internal physiology.

6 Jun 2022

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

Approximately half of children with neuroblastoma - a childhood cancer that develops from immature nerve cells - have a form that indicates a high likelihood of recurrence.

6 Jun 2022

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

A new clinical trial studying the effectiveness of a combination of immunotherapy treatments could be more effective for patients with ovarian cancer who are resistant to traditional interventions.

6 Jun 2022

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

Researchers reviewed and analyzed data from SARS-CoV-2 serosurveys supported by the United States Centers for Disease Prevention and Control in the low- and middle-income countries.

6 Jun 2022

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine

A recent article demonstrated that SARS-CoV-2 mutants and vaccine variability stem from ribonucleic acid polymerase inaccuracy.

6 Jun 2022

Finsen Tech ties up with market opportunity specialist Sanollo to open international doors for its UVC disinfection products

Global company Finsen Tech, the world-renowned pioneers in UVC innovation to control the spread of infectious pathogens, has entered into an alliance with successful UK-based market opportunity specialist Sanollo.

6 Jun 2022

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the immunogenicity of booster doses of alum-adjuvanted SCB-2019 vaccine candidate's three formulations.

6 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Efficacy News and Research

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Sponge-like solar cells could form the basis for less-invasive pacemakers or similar medical devices

Novel approach to drug repurposing incorporates two-stage prediction and machine learning

Study demonstrates how some fast-growing bacteria can evade antibiotic treatment

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

Study identifies some breast cancer patients who can avoid radiotherapy

New FR-targeting, micropinocytosis-mediated bioconjugate attacks K-Ras mutant pancreatic cancer

Color-changing mouse model aids in better visualization of internal physiology

Study confirms the benefits of 'bridge therapy' for some children with high-risk neuroblastoma

New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

Details of SARS-CoV-2 seroprevalence surveys supported by the US CDC

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine

Finsen Tech ties up with market opportunity specialist Sanollo to open international doors for its UVC disinfection products

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Exploring the effectiveness of various treatments in people with axial spondyloarthritis

Novel approach identifies potent drug-like molecules that bind to cancer protein of interest

New method to combat malaria turns the disease against itself

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News